Posted in | News | Nanobusiness

Nanogen and Menarini to Capture European Molecular Diagnostics Market

Nanogen, Inc., developer of molecular and rapid diagnostic products, has entered into an agreement with A. Menarini Diagnostics S.r.l., a division of The Menarini Group, the leading Italian pharmaceutical and diagnostics group, to commercialize CE marked IVD infectious disease kits based on Nanogen's proprietary MGB technology.

The arrangement combines Nanogen's strength in real-time PCR IVD product development with Menarini's significant market presence in the major EU countries and their rapidly expanding reach into the developing Eastern European markets. Under the terms of the agreement the kits will be manufactured by Nanogen and branded as Menarini products. The first products are expected to be introduced to the market in 2009 and will target infectious disease diagnostics.

“Molecular diagnostics is a high growth segment of the global IVD market and real-time PCR has become a gold standard diagnostic technology,” said Howard Birndorf, CEO of Nanogen. “We are pleased to have a partner like Menarini that can help bring our innovative technology to the $1 billion European market. We believe our strong technology and product capabilities together with Menarini's local sales strength will open a new market and revenue stream for Nanogen and will make a highly competitive offering in Europe.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanogen. (2019, February 15). Nanogen and Menarini to Capture European Molecular Diagnostics Market. AZoNano. Retrieved on July 14, 2024 from https://www.azonano.com/news.aspx?newsID=8562.

  • MLA

    Nanogen. "Nanogen and Menarini to Capture European Molecular Diagnostics Market". AZoNano. 14 July 2024. <https://www.azonano.com/news.aspx?newsID=8562>.

  • Chicago

    Nanogen. "Nanogen and Menarini to Capture European Molecular Diagnostics Market". AZoNano. https://www.azonano.com/news.aspx?newsID=8562. (accessed July 14, 2024).

  • Harvard

    Nanogen. 2019. Nanogen and Menarini to Capture European Molecular Diagnostics Market. AZoNano, viewed 14 July 2024, https://www.azonano.com/news.aspx?newsID=8562.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.